413 results on '"Kaltenbach, Lisa A."'
Search Results
2. Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS
3. RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and design
4. Access to Mobile Health Interventions Among Patients Hospitalized With Heart Failure: Insights Into the Digital Divide From the CONNECT-HF mHealth Substudy
5. Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HF
6. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States
7. Abstract 13741: Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation
8. Abstract 341: Regional Variation in Cardiac Arrest Response and Outcomes in North Carolina - A Call to Action
9. Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs
10. Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) – Diabetes: rationale and design
11. Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry
12. The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HF
13. Patterns of care for first-detected atrial fibrillation: Insights from the Get With The Guidelines® – Atrial Fibrillation registry
14. Adverse Change in Employment Status After Acute Myocardial Infarction
15. Characteristics and Outcomes of Patients With History of CABG Undergoing Cardiac Catheterization Via the Radial Versus Femoral Approach
16. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study.
17. Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study
18. Percutaneous Coronary Intervention Operator Profiles and Associations With In-Hospital Mortality
19. Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction
20. Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry
21. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial
22. Trends in Usage and Clinical Outcomes of Coronary Atherectomy: A Report From the National Cardiovascular Data Registry CathPCI Registry
23. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation
24. CHARACTERIZING THE DIGITAL DIVIDE & ACCESS TO MOBILE HEALTH INTERVENTIONS IN HEART FAILURE: INSIGHTS FROM THE CONNECT-HF MHEALTH SUBSTUDY
25. ADJUSTMENT OF GUIDELINE-DIRECTED MEDICAL THERAPY ONE YEAR POST-HEART FAILURE HOSPITALIZATION FALLS SHORT: INSIGHTS FROM THE CONNECT-HF TRIAL
26. Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions: A Report From the National Cardiovascular Data Registry
27. Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women
28. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention: Report From the NCDR CathPCI Registry
29. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation
30. Health System–Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial
31. Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry
32. Abstract 17585: Change in Employment Status After Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Study
33. Abstract 15991: Assessing Longitudinal Medication Use in Pragmatic Clinical Trials: Insights From the ARTEMIS Trial
34. Abstract 13760: Symptom Onset to Door Time and Door to Balloon Time: Can We Further Decrease Mortality Post STEMI?
35. Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial.
36. EN-728-01 RACIAL AND ETHNIC INEQUITIES IN ORAL ANTICOAGULATION AND ASSOCIATED OUTCOMES FOR PATIENTS WITH ATRIAL FIBRILLATION - THE GET WITH THE GUIDELINES ATRIAL FIBRILLATION REGISTRY
37. CE-539-01 RACIAL AND ETHNIC INEQUITIES IN ORAL ANTICOAGULATION AND ASSOCIATED OUTCOMES FOR PATIENTS WITH ATRIAL FIBRILLATION - THE GET WITH THE GUIDELINES ATRIAL FIBRILLATION REGISTRY
38. Assessing Stroke Patients for Rehabilitation During the Acute Hospitalization: Findings From the Get With The Guidelines–Stroke Program
39. Race and Sex Differences in Post–Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned Rehospitalization
40. Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
41. Downstream Testing and Subsequent Procedures After Coronary Computed Tomographic Angiography Following Coronary Stenting in Patients ≥65 Years of Age
42. Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent Thrombosis
43. Performance On Guideline Directed Medical Therapy Remains Low In A Cluster-randomized Trial: Results From CONNECT-HF
44. Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
45. INTERVENTION TO IMPROVE GUIDELINE-BASED CARE FOR DIABETES AND CARDIOVASCULAR DISEASE IS EFFECTIVE IN BLACK AND HISPANIC POPULATIONS
46. CHARACTERISTICS OF PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PRESCRIBED SGLT-2I AND/OR GLP-1RA AMONG CARDIOLOGY CLINICS IN THE US: INSIGHTS FROM A LARGE IMPLEMENTATION TRIAL
47. PERSISTENCE AND DISCONTINUATION OF SGLT-2I AND GLP-1RA AMONG PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE TREATED IN US CARDIOLOGY CLINICS: INSIGHTS FROM THE COORDINATE-DIABETES TRIAL
48. Adjustment for Multiple Cardiovascular Risk Factors Using a Summary Risk Score
49. Hospital Variability in the Rate of Finding Obstructive Coronary Artery Disease at Elective, Diagnostic Coronary Angiography
50. Patterns and Predictors of Evidence-Based Medication Continuation Among Hospitalized Heart Failure Patients (from Get With the Guidelines–Heart Failure)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.